A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223

被引：0
|
作者：
Viviana Frantellizzi
Fabio Monari
Manlio Mascia
Renato Costa
Giuseppe Rubini
Angela Spanu
Alessio Farcomeni
Elisa Lodi Rizzini
Luca Cindolo
Alessandra Murabito
Valentina Lavelli
Susanna Nuvoli
Laura Cosma
Valeria Dionisi
Anna Giulia Nappi
Marco Andreola
Giuseppe De Vincentis
机构：
[1] “Sapienza” University of Rome,Department of Molecular Medicine Sapienza
[2] S.Orsola-Malpighi Hospital,Radiation Oncology Center
[3] “Spirito Santo” Hospital,Unit of Nuclear Medicine
[4] University of Palermo,Unit of Nuclear Medicine, Biomedical Department of Internal and Specialist Medicine
[5] University of Bari “Aldo Moro”,Nuclear Medicine Department
[6] University of Sassari,Unit of Nuclear Medicine, Department of Medical Surgical and Experimental Sciences
[7] University of Rome “Tor Vergata”,Department of Economics & Finance
[8] S.Orsola-Malpighi Hospital,Nuclear Medicine Unit
[9] “Villa Stuart” Private Hospital,Department of Urology
[10] “Sapienza” University of Rome,Department of Radiological Sciences, Oncology and Anatomical Pathology Sapienza
来源：
Aging Clinical and Experimental Research | 2021年 / 33卷
关键词：
mCRPC; Elderly; Overall survival; Radium-223; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：651 / 658
页数：7
相关论文
共 50 条
  • [41] External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-resistant Prostate Cancer Patients Treated with Abiraterone
    Ravi, Praful
    Mateo, Joaquin
    Lorente, David
    Zafeiriou, Zafeiris
    Altavilla, Amelia
    Ferraldeschi, Roberta
    Sideris, Spyridon
    Grist, Emily
    Smith, Alan
    Wong, Sophia
    Bianchini, Diletta
    Attard, Gerhardt
    de Bono, Johann S.
    [J]. EUROPEAN UROLOGY, 2014, 66 (01) : 8 - 11
  • [42] Radium-223 for Men with Pretreated Metastatic Castrate Resistant Prostate Cancer, Too Little Too Late?
    Kalash, R.
    Horne, Z. D.
    Smith, R. P.
    Champ, C. E.
    Appleman, L.
    Beriwal, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E121 - E121
  • [43] Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
    Parker, C.
    Nilsson, S.
    Heinrich, D.
    Helle, S. I.
    O'Sullivan, J. M.
    Fossa, S. D.
    Chodacki, A.
    Wiechno, P.
    Logue, J.
    Seke, M.
    Widmark, A.
    Johannessen, D. C.
    Hoskin, P.
    Bottomley, D.
    James, N. D.
    Solberg, A.
    Syndikus, I.
    Kliment, J.
    Wedel, S.
    Boehmer, S.
    Dall'Oglio, M.
    Franzen, L.
    Coleman, R.
    Vogelzang, N. J.
    O'Bryan-Tear, C. G.
    Staudacher, K.
    Garcia-Vargas, J.
    Shan, M.
    Bruland, O. S.
    Sartor, O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (03): : 213 - 223
  • [44] Utilization of Radium-223 in Metastatic Prostate Cancer Patients and Novel Prognostic Indicators In Radium-223 Patients
    Parsons, M. W.
    Tward, J. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E899 - E899
  • [45] Survival and immune analysis of radium-223 in patients with metastatic prostate cancer.
    Kim, Joseph W.
    Shin, Min
    Kang, Youna
    Kang, Insoo
    Petrylak, Daniel Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
    van der Doelen, Maarten J.
    Stockhaus, Agnes
    Ma, Yuanjun
    Mehra, Niven
    Yachnin, Jeffrey
    Gerritsen, Winald R.
    Nilsson, Sten
    van Oort, Inge M.
    Ullen, Anders
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (10) : 3325 - 3334
  • [47] Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival
    Francini, Edoardo
    Fiaschi, Anna I.
    Petrioli, Roberto
    Bianco, Vincenzo
    Laera, Letizia
    Francini, Filippo
    Roviello, Giandomenico
    [J]. ANTI-CANCER DRUGS, 2015, 26 (08) : 910 - 911
  • [48] Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
    Maarten J. van der Doelen
    Agnes Stockhaus
    Yuanjun Ma
    Niven Mehra
    Jeffrey Yachnin
    Winald R. Gerritsen
    Sten Nilsson
    Inge M. van Oort
    Anders Ullén
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3325 - 3334
  • [49] The National Radium-223 Dichloride Audit group: Data from patients in UK oncology centers with metastatic castration-resistant prostate cancer treated with radium-223 dichloride.
    Randhawa, Manreet
    Jones, Robert J.
    Stratton, Irene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Biomarker analysis of phase (Ph) IB trial of radium-223 (Rad) and niraparib (Nira) in patients (Pts) with metastatic castrate-resistant prostate cancer (mCRPC) (NiraRad).
    Yang, Eddy Shih-Hsin
    Leiby, Benjamin
    Sonpavde, Guru P.
    Einstein, David Johnson
    Quinn, Zachary L.
    Szmulewitz, Russell Zelig
    Sartor, A. Oliver
    Kelly, William Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345